WENDY WEINSTEIN: Open Payments
NPI 1679523484 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,199 in 209 payments from 15 companies in 2025. Trend: 2023 $111,122 · 2024 $90,638 · 2025 $57,199
Speaker / faculty: $46,917Travel & lodging: $6,293Food & beverage: $3,989
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 53 | $29,319 |
| Otsuka America Pharmaceutical, Inc. | 32 | $15,209 |
| ABBVIE INC. | 53 | $6,569 |
| E.R. Squibb & Sons, L.L.C. | 7 | $4,825 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $408 |
| Alkermes, Inc. | 8 | $249 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| Axsome Therapeutics, Inc. | 6 | $111 |
| Neurocrine BioSciences, Inc. | 5 | $108 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
Products named: FANAPT, REXULTI, VRAYLAR, COBENFY, CAPLYTA, INVEGA SUSTENNA, ARISTADA, LYBALVI.
Industry payments across NY — which companies pay providers there.
